Symbol
| APOA4
| contributors: mct - updated : 17-02-2017
|
HGNC name
| apolipoprotein A-IV
|
HGNC id
| 602
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in follicular fluid from Polycystic ovary syndrome (PCOS) patients compared with those from normal controls | |
Susceptibility
|
to low HDL-cholesterol |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| association of APOA4 with disease activity in patients with Crohn disease | Therapy target
|
System | Type | Disorder | Pubmed |
diabete | type 1 | | |
APOA4 may provide a therapeutic target for the regulation of glucose-stimulated insulin secretion and treatment of diabetes | neurology | neurodegenerative | alzheimer | |
enhancing levels of APOA4 may have therapeutic potential in AD treatment |
| | |
| the expressions of Apoa4-AS and Apoa4 are both abnormally elevated in the liver of ob/ob mice and patients with fatty liver disease |